These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 35239330)
1. Treatment of Wound Infections in a Mouse Model Using Zn Peng H; Rossetto D; Mansy SS; Jordan MC; Roos KP; Chen IA ACS Nano; 2022 Mar; 16(3):4756-4774. PubMed ID: 35239330 [TBL] [Abstract][Full Text] [Related]
2. Design of Phage-Cocktail-Containing Hydrogel for the Treatment of Shafigh Kheljan F; Sheikhzadeh Hesari F; Aminifazl MS; Skurnik M; Gholadze S; Zarrini G Viruses; 2023 Mar; 15(3):. PubMed ID: 36992511 [TBL] [Abstract][Full Text] [Related]
3. Controlled phage therapy by photothermal ablation of specific bacterial species using gold nanorods targeted by chimeric phages. Peng H; Borg RE; Dow LP; Pruitt BL; Chen IA Proc Natl Acad Sci U S A; 2020 Jan; 117(4):1951-1961. PubMed ID: 31932441 [TBL] [Abstract][Full Text] [Related]
4. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients. Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776 [TBL] [Abstract][Full Text] [Related]
5. Engineered Bacteriophages Containing Anti-CRISPR Suppress Infection of Antibiotic-Resistant P. aeruginosa. Qin S; Liu Y; Chen Y; Hu J; Xiao W; Tang X; Li G; Lin P; Pu Q; Wu Q; Zhou C; Wang B; Gao P; Wang Z; Yan A; Nadeem K; Xia Z; Wu M Microbiol Spectr; 2022 Oct; 10(5):e0160222. PubMed ID: 35972246 [TBL] [Abstract][Full Text] [Related]
6. Engineered Superinfective Pf Phage Prevents Dissemination of Pseudomonas aeruginosa in a Mouse Burn Model. Prokopczuk FI; Im H; Campos-Gomez J; Orihuela CJ; Martínez E mBio; 2023 Jun; 14(3):e0047223. PubMed ID: 37039641 [TBL] [Abstract][Full Text] [Related]
8. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis. Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558 [TBL] [Abstract][Full Text] [Related]
9. Alginate microbeads and hydrogels delivering meropenem and bacteriophages to treat Pseudomonas aeruginosa fracture-related infections. Chen B; Benavente LP; Chittò M; Wychowaniec JK; Post V; D'Este M; Constant C; Zeiter S; Feng W; Moreno MG; Trampuz A; Wagemans J; Onsea J; Richards RG; Lavigne R; Moriarty TF; Metsemakers WJ J Control Release; 2023 Dec; 364():159-173. PubMed ID: 37866403 [TBL] [Abstract][Full Text] [Related]
10. Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder Formulation. Chang RYK; Chen K; Wang J; Wallin M; Britton W; Morales S; Kutter E; Li J; Chan HK Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158280 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and safety evaluation of intravenously administered Wang S-y; Tan X; Liu Z-q; Ma H; Liu T-b; Yang Y-q; Ying Y; Gao R-y; Zhang D-z; Ma Y-f; Chen K; Lin L; Jiang Z-h; Yu J-l Microbiol Spectr; 2024 Jan; 12(1):e0188223. PubMed ID: 38014983 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of phage cocktail AB-SA01 therapy in diabetic mouse wound infections caused by multidrug-resistant Staphylococcus aureus. Kifelew LG; Warner MS; Morales S; Vaughan L; Woodman R; Fitridge R; Mitchell JG; Speck P BMC Microbiol; 2020 Jul; 20(1):204. PubMed ID: 32646376 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. Jault P; Leclerc T; Jennes S; Pirnay JP; Que YA; Resch G; Rousseau AF; Ravat F; Carsin H; Le Floch R; Schaal JV; Soler C; Fevre C; Arnaud I; Bretaudeau L; Gabard J Lancet Infect Dis; 2019 Jan; 19(1):35-45. PubMed ID: 30292481 [TBL] [Abstract][Full Text] [Related]
14. Two Novel Bacteriophages Improve Survival in Jeon J; Yong D Appl Environ Microbiol; 2019 May; 85(9):. PubMed ID: 30824445 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial efficacy and toxicity of novel CAMPs against P. aeruginosa infection in a murine skin wound infection model. Yang M; Zhang C; Hansen SA; Mitchell WJ; Zhang MZ; Zhang S BMC Microbiol; 2019 Dec; 19(1):293. PubMed ID: 31842727 [TBL] [Abstract][Full Text] [Related]
16. Selective Photothermal Therapy Based on Lipopolysaccharide Aptamer Functionalized MoS Lv J; Li B; Luo T; Nie C; Pan W; Ge X; Zheng J; Rui Y; Zheng L Adv Healthc Mater; 2023 Jun; 12(15):e2202794. PubMed ID: 36812882 [TBL] [Abstract][Full Text] [Related]
17. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa. Wang J; Hu B; Xu M; Yan Q; Liu S; Zhu X; Sun Z; Reed E; Ding L; Gong J; Li QQ; Hu J Int J Mol Med; 2006 Feb; 17(2):309-17. PubMed ID: 16391831 [TBL] [Abstract][Full Text] [Related]
18. Successful Use of Phage and Antibiotics Therapy for the Eradication of Two Bacterial Pathogens from the Respiratory Tract of an Infant. Morozova VV; Kozlova YN; Tikunova NV Methods Mol Biol; 2024; 2734():237-243. PubMed ID: 38066373 [TBL] [Abstract][Full Text] [Related]
19. A window of opportunity to control the bacterial pathogen Pseudomonas aeruginosa combining antibiotics and phages. Torres-Barceló C; Arias-Sánchez FI; Vasse M; Ramsayer J; Kaltz O; Hochberg ME PLoS One; 2014; 9(9):e106628. PubMed ID: 25259735 [TBL] [Abstract][Full Text] [Related]
20. Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice. Vinodkumar CS; Kalsurmath S; Neelagund YF Indian J Pathol Microbiol; 2008; 51(3):360-6. PubMed ID: 18723958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]